Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

NCT00421187 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Unable to recruit subjects in the Turkey site.

Conditions

Febrile Neutropenia

Interventions

DRUG: Liposomal amphotericin B (AmBisome®)
DRUG: Liposomal amphotericin B (AmBisome®)

Sponsor

Gilead Sciences